A Beginner Framework for a Safer Peptide Plan
App Library Tools Pricing Download
[Guide · Protocols and safety]

A beginner framework for a safer peptide plan

6 min read · Also in the Dose Track app under Learn · Updated

Short answer: A plan is a dose, a schedule, a set length and a check-in date, written down before you start. Start low, add one compound at a time, keep a log, recheck labs with a clinician, and know which symptoms mean cut back and which mean stop.

Start low

Research info, not a recommendation. Amounts, schedules and timing in this section come from studies (often in animals) and from how people commonly use these compounds. Most are not FDA-approved doses. Your dose is a decision for you and your prescriber.

A common practice is to start below the low end of the range described in research or by your clinician, hold for one to two weeks, and only then move up in small steps. For BPC-157, for example, 250 mcg once a day is a commonly reported starting amount in community use. These are not tested doses.

More is rarely better. Side effects tend to rise with the dose, and for many compounds there is no evidence that higher amounts add benefit.

Change one thing at a time

  • Add one new compound at a time.
  • Do not change the dose, timing and compound in the same week.
  • Hold a dose for a couple of weeks before judging it.
  • Avoid starting a new supplement or training plan the same week.

Otherwise you cannot tell what caused a change. See stacking basics.

Set a length and an end date

Write the start and end dates down before day one. Community conventions for research peptides, which have not been tested in trials:

  • Growth hormone peptides: often 8 to 12 weeks, then a break.
  • Repair peptides (BPC-157, TB-500): often 4 to 6 weeks around an injury.
  • GLP-1 drugs: usually ongoing under a prescriber, with dose changes rather than breaks.

A break also gives you a fresh baseline to compare against.

What to track

With every dose: the time, amount, injection site and any symptoms. Once a week: sleep, energy, recovery, any new symptoms, and how the injection sites look.

For growth hormone peptides, IGF-1 is the usual blood marker. Get a baseline, then recheck with your clinician after a few weeks at a steady dose. For GLP-1 drugs, weight, fasting glucose or HbA1c and how you tolerate each step matter most.

Cut back or stop?

Stop and get medical help: allergic reaction (hives, swelling, trouble breathing), spreading infection, fever with dosing, severe stomach pain or vomiting on a GLP-1 drug, chest pain, fainting, or new irregular heartbeat.

Talk to your prescriber about lowering the dose: water retention, tingling hands, tiredness for hours after a dose, or hunger that disrupts your day.

Tell your prescriber about every compound you take, especially with prescription medicines.

Using Dose Track for this

Key points

  • Write the dose, schedule, length and check-in date down before you start.
  • Start low and change one thing at a time.
  • Log every dose and symptom; recheck labs with a clinician.
  • Know which symptoms mean stop now and which mean talk about lowering the dose.

See also: Goals and conditions · Dosing schedules from FDA labels

This guide is general education, not medical advice. Follow your medicine's label and your prescriber.

Compounds in this guide

BPC-157Compound guide in the Dose Track library. TB-500Compound guide in the Dose Track library. IpamorelinCompound guide in the Dose Track library. SemaglutideCompound guide in the Dose Track library.
Your first peptide: a starter checklistBefore your first dose: know the compound, write down your goal, get baseline labs with a clinician, have… Stacking basics: combining peptides carefullyStacking means taking two or more compounds at the same time. Some pairs make sense on paper because they… Side effects: what to knowSide effects depend on the class. GLP-1 drugs mostly cause stomach and gut symptoms, especially when the… Lab testing and COAs: reading the dataA Certificate of Analysis (COA) is a lab report for one batch. HPLC tells you how pure the sample is; mass…

Frequently asked questions

What is a typical BPC-157 starting amount?+
In community use, 250 mcg once a day is commonly reported. It is not a tested dose and BPC-157 is not approved; talk to a clinician.
Do peptides need a break?+
For research peptides, breaks are a community convention, not something tested in trials. GLP-1 drugs are usually taken long-term under a prescriber.
What should I track on a peptide plan?+
Each dose with time, amount, site and symptoms, a weekly check-in, and labs your clinician recommends, such as IGF-1 for growth hormone peptides.

Sources

  1. Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;139(5):552-61
  2. Ozempic prescribing information and Instructions for Use (Novo Nordisk)
  3. He L et al. Pharmacokinetics, distribution, metabolism and excretion of BPC 157 in rats and dogs. Front Pharmacol 2022;13:1026182

All guides · Compound library · Help center · Glossary